Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

147.96
+7.675.47%
Volume:11.68M
Turnover:1.69B
Market Cap:59.07B
PE:-18.48
High:149.32
Open:139.96
Low:138.09
Close:140.34
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.03
T/O Rate:3.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.74
PE(LYR):-20.38

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)

TIPRANKS
·
Aug 06

Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future

Dow Jones
·
Aug 06

Pre-Market Outlook: US Index Futures Mixed; Memory Chip Stocks Slide on SanDisk and Western Digital Guidance Miss

Stock News
·
Aug 06

Novavax Lifts Annual Revenue Forecast as Licensing Bets Offset Weak Vaccine Demand

Reuters
·
Aug 06

U.S. Stocks on the MOVE-Cheniere Energy, TPG, Constellation Energy

Reuters
·
Aug 06

Roivant Q1 FY27 Net Loss Widens to $290.61 Million; Revenue Slips to $1.44 Million

Reuters
·
Aug 06

Sandisk, AppLovin, Moderna, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 06

Moderna Shares up 4% Premarket After US FDA Approval for Flu Vaccine

THOMSON REUTERS
·
Aug 06

Moderna Secures FDA Approval for First mRNA Flu Vaccine After Regulatory Hurdles, Commercial Prospects Remain Uncertain

Stock News
·
Aug 06

PRESS Digest -Wall Street Journal - August 6

Reuters
·
Aug 06

PRESS Digest-New York Times Business News - August 6

Reuters
·
Aug 06

US FDA Approves First mRNA Flu Shot from Moderna

Reuters
·
Aug 06

Moderna: Gets U.S. FDA Approval for Influenza Vaccine Mflusiva for Use in Adults 50 Years and Older

THOMSON REUTERS
·
Aug 06

Moderna: Expects Supply of Influenza Vaccine Mflusiva to be Available in Select Retailers in Coming Weeks

THOMSON REUTERS
·
Aug 06

Moderna Shingles Vaccine Trial Terminated: What It Means for MRNA Investors

TIPRANKS
·
Aug 06

Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine

Dow Jones
·
Aug 05

Moderna announces initiation of Phase 1 trial of mRNA-1469

TIPRANKS
·
Aug 04

Moderna Publishes Transcript of Q2 2026 Earnings Call

Reuters
·
Aug 04

Moderna: Mrna-1469 Phase 1 Trial Conducted in Canada as Part of Expanded Collaboration with Coalition for Epidemic Preparedness Innovations

THOMSON REUTERS
·
Aug 04

Moderna: Under Cepi Agreement, Commits Minimum 500,000 Doses of Mrna-1469 Vaccine for Low- and Middle-Income Countries Under Access Pricing

THOMSON REUTERS
·
Aug 04